Spontaneous normalization of ovarian function and pregnancy in a patient with resistant ovary syndrome

Author(s):  
Andreas Mueller ◽  
Alexander Berkholz ◽  
Ralf Dittrich ◽  
Ludwig Wildt
2020 ◽  
Vol 16 (28) ◽  
pp. 24-34
Author(s):  
O.A. Pustotina ◽  

The article presents key data on the physiology of inositols in the body, their pathogenetic role in the development of polycystic ovary syndrome, and the possibilities of myo-inositol and D-chiro-inositol in the restoration of ovarian function, metabolic parameters, and overcoming of infertility.


2002 ◽  
Vol 78 ◽  
pp. S36 ◽  
Author(s):  
Nicholas A Cataldo ◽  
Fahim Abbasi ◽  
Tracey L McLaughlin ◽  
Patricia Y Fechner ◽  
Gerald M Reaven ◽  
...  

Author(s):  
Amanda Ladrón de Guevara ◽  
Nicolás Crisosto ◽  
Bárbara Echiburú ◽  
Jessica Preisler ◽  
Natalie Vantman ◽  
...  

1975 ◽  
Vol 30 (10) ◽  
pp. 699 ◽  
Author(s):  
C. J. DEWHURST ◽  
EDMOND B. DE KOOS ◽  
H. P. FERREIRA

2018 ◽  
Vol 9 (4) ◽  
pp. 123-134 ◽  
Author(s):  
Renato Pasquali

Polycystic ovary syndrome (PCOS) is a common disorder in women in their reproductive years and is characterized by androgen excess, ovulatory dysfunction, and polycystic ovarian morphology. It is also associated with several metabolic abnormalities, particularly insulin resistance and obesity, which play an important role in the pathophysiology of PCOS and, in particular, negatively influence ovarian function and fertility. This review article summarizes the available treatment for women with PCOS. Specifically, current and potentially new therapies are discussed.


Author(s):  
Jia Zhu ◽  
Natàlia Pujol-Gualdo ◽  
Laura B L Wittemans ◽  
Cecilia M Lindgren ◽  
Triin Laisk ◽  
...  

Abstract Context Polycystic ovary syndrome (PCOS) is characterized by ovulatory dysfunction and hyperandrogenism and can be associated with cardiometabolic dysfunction, but it remains unclear which of these features are inciting causes and which are secondary consequences. Objective To determine whether ovarian function is necessary for genetic risk factors for PCOS to produce nonreproductive phenotypes. Design, Setting, and Participants Cohort of 176 360 men in the UK Biobank and replication cohort of 37 348 men in the Estonian Biobank. Main Outcome Measures We calculated individual PCOS polygenic risk scores (PRS), tested for association of these PRS with PCOS-related phenotypes using linear and logistic regression and performed mediation analysis. Results For every 1 SD increase in the PCOS PRS, men had increased odds of obesity (odds ratio [OR]: 1.09; 95% CI, 1.08-1.10; P = 1 × 10-49), type 2 diabetes mellitus (T2DM) (OR: 1.08; 95% CI, 1.05-1.10; P = 3 × 10-12), coronary artery disease (CAD) (OR: 1.03; 95% CI, 1.01-1.04; P = 0.0029), and marked androgenic alopecia (OR: 1.03; 95% CI, 1.02-1.05; P = 3 × 10-5). Body mass index (BMI), hemoglobin A1c, triglycerides, and free androgen index increased as the PRS increased, whereas high-density lipoprotein cholesterol and SHBG decreased (all P < .0001). The association between the PRS and CAD appeared to be completely mediated by BMI, whereas the associations with T2DM and marked androgenic alopecia appeared to be partially mediated by BMI. Conclusions Genetic risk factors for PCOS have phenotypic consequences in men, indicating that they can act independently of ovarian function. Thus, PCOS in women may not always be a primary disorder of the ovaries.


Sign in / Sign up

Export Citation Format

Share Document